Literature DB >> 24092783

Complete Genome Sequence of Reticuloendotheliosis Virus Strain MD-2, Isolated from a Contaminated Turkey Herpesvirus Vaccine.

Junping Li1, Chenghuai Yang, Qihong Li, Huijiao Li, Yecai Xia, Dan Liu, Kangzhen Yu, Hanchun Yang.   

Abstract

Here, we present the complete genomic sequence of a reticuloendotheliosis virus (REV) isolated from a contaminated turkey herpesvirus (HVT) vaccine. This report will be helpful for epidemiological studies on REV infection in avian flocks.

Entities:  

Year:  2013        PMID: 24092783      PMCID: PMC3790087          DOI: 10.1128/genomeA.00785-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Reticuloendotheliosis virus (REV), classified as a gammaretrovirus, causes immunosuppression, running disease, and lymphomas. The representative strains of REV include the defective REV-T and the nondefective REV-A, the spleen necrosis virus (SNV), duck infectious anemia virus, and chick syncytial virus (CSV) (1). All REV isolates are antigenically related to each other and have a wide avian host range that includes chickens, turkeys, ducks, geese, pheasants, peafowl, Japanese quail, and prairie chickens (2–4). REV has been found as a contaminant in commercial vaccines in some countries as early as the 1970s (5, 6). In recent years, there were cases of vaccines contaminated with REV in China and other countries (7–9). However, there is no report about the complete genome sequence of REV isolated from a contaminated vaccine. REV strain MD-2 was isolated from a batch of commercial freeze-dried turkey herpesvirus vaccines in 2007 and propagated in chicken embryo fibroblasts (CEF). According to the Wizard Genomic DNA purification kit (Promega, Madison, WI) protocol, total genomic DNA was extracted from infected CEF and used as template for proviral DNA amplification. Seven pairs of primers were designed in overlapping regions for PCR amplification. The 7 amplified PCR products were purified and cloned into pMD18-T vector (Takara, Dalian, China) and were sequenced by BGI (Beijing, China). The genomic sequence was assembled using the SeqMan function in the DNAStar sequence analysis software (DNAStar, Inc., Madison, WI). The long terminal repeat (LTR) sequence was deduced based on the notion that both LTRs are identical in the REV proviral genome. The proviral genome cDNA is 8,284 nucleotides long and exhibits a genetic organization characteristic of replication-competent gammaretroviruses. The proteins were deduced according to the features of gammaretroviruses and previous studies (10, 11). The pol gene is situated in the continuous open reading frame (ORF) as gag and translated gag-pol polyprotein via termination suppression of an amber stop codon (12). The env gene is located in an independent ORF, and expression of the env gene is driven by a spliced mRNA. The gag precursor protein is 499 amino acids long and is cleaved into 4 structural proteins, matrix (MA) extending from amino acids 2 to 114, p18 from amino acids 115 to 199, capsid (CA) from amino acids 200 to 442, and nucleocapsid domain (NC) from amino acids 443 to 494. The env precursor is 587 amino acids long with a signal peptide of 36 amino acids located in the NH2 terminal region, and it is cleaved by cellular furin on amino acid 398 to produce the mature surface (SU) and transmembrane (TM) proteins. The genome of MD-2 strain is most similar to that of strain HLJR0901, isolated in 2009 in China (13), with 99.9% identity. This report will be helpful for epidemiological study investigation on REV infection in an avian flocks.

Nucleotide sequence accession number.

The complete genome sequence of the REV strain MD-2 is available in GenBank under the accession no. JX912710.
  12 in total

1.  Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.

Authors:  K M Felsenstein; S P Goff
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Effects of retroviral envelope-protein cleavage upon trafficking, incorporation, and membrane fusion.

Authors:  Swapna Apte; David Avram Sanders
Journal:  Virology       Date:  2010-06-29       Impact factor: 3.616

3.  Phylogenetic analyses indicate little variation among reticuloendotheliosis viruses infecting avian species, including the endangered Attwater's prairie chicken.

Authors:  Ryan L Bohls; Jose A Linares; Shannon L Gross; Pam J Ferro; Nova J Silvy; Ellen W Collisson
Journal:  Virus Res       Date:  2006-02-23       Impact factor: 3.303

4.  Full genome sequences of two reticuloendotheliosis viruses contaminating commercial vaccines.

Authors:  Qinfang Liu; Jixun Zhao; Jingliang Su; Juan Pu; Guozhong Zhang; Jinhua Liu
Journal:  Avian Dis       Date:  2009-09       Impact factor: 1.577

Review 5.  Detection of reticuloendotheliosis virus in live virus vaccines of poultry.

Authors:  A Fadly; M C Garcia
Journal:  Dev Biol (Basel)       Date:  2006

6.  Serologic differences among nondefective reticuloendotheliosis viruses.

Authors:  P Y Chen; Z Cui; L F Lee; R L Witter
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

7.  Purification and chemical and immunological characterization of avian reticuloendotheliosis virus gag-gene-encoded structural proteins.

Authors:  W P Tsai; T D Copeland; S Oroszlan
Journal:  Virology       Date:  1985-01-30       Impact factor: 3.616

8.  Detection of reticuloendotheliosis virus as a contaminant of fowl pox vaccines.

Authors:  A M Awad; H S Abd El-Hamid; A A Abou Rawash; H H Ibrahim
Journal:  Poult Sci       Date:  2010-11       Impact factor: 3.352

9.  Proventriculitis, "nakanuke" and reticuloendotheliosis in chickens following vaccination with herpesvirus of turkeys (HVT)

Authors:  C A Jackson; S E Dunn; D I Smith; P T Gilchrist; P A Macqueen
Journal:  Aust Vet J       Date:  1977-09       Impact factor: 1.281

10.  Isolation of a reticuloendotheliosis virus from chickens inoculated with Marek's disease vaccine.

Authors:  N Yuasa; I Yoshida; T Taniguchi
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1976
View more
  2 in total

1.  Co-Infection with Marek's Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek's Disease Vaccine Efficacy.

Authors:  Guo-Rong Sun; Yan-Ping Zhang; Lin-Yi Zhou; Hong-Chao Lv; Feng Zhang; Kai Li; Yu-Long Gao; Xiao-Le Qi; Hong-Yu Cui; Yong-Qiang Wang; Li Gao; Qing Pan; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Viruses       Date:  2017-06-21       Impact factor: 5.048

2.  An outbreak in three-yellow chickens with clinical tumors of high mortality caused by the coinfection of reticuloendotheliosis virus and Marek's disease virus: a speculated reticuloendotheliosis virus contamination plays an important role in the case.

Authors:  Mengya Shi; Min Li; Peikun Wang; Weiwei Wang; Haijuan Li; Yanli Gao; Lulu Lin; Teng Huang; Ping Wei
Journal:  Poult Sci       Date:  2020-09-25       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.